QFIN Slides 32% in a Month as JP Morgan Cuts to Underweight

QFIN enters the final stretch of October having shed nearly a third of its value over the past month, yet short interest is only now beginning to rebuild from a trough, and options traders remain conspicuously unbothered by the carnage.

The analyst story is the sharpest edge here. JP Morgan's Katherine Lei downgraded QFIN to Underweight on August 26, cutting her price target from $13.50 to $9.00, a move that followed the stock's single worst day in recent memory when it fell more than 20% after earnings. Lei had already trimmed her target earlier in August. That sequence from Overweight to Neutral in November 2025, and now to Underweight, represents a decisive shift from one of the few active bellwether voices on this name. The contrast with other firms is stark: Jefferies still carries a Buy but cut its target to $23.40 in March, and the consensus mean price target sits near $99, a figure so far above the current $5.48 that it reflects aggregated stale data across many price points and should be treated with caution rather than as genuine street conviction. The most recent actionable data points to a deeply bearish skew from the most active analyst.

Positioning in the lending market tells a different story, one that is almost comically loose given the price action. Borrow availability is extraordinarily wide at 2,393%, meaning roughly 24 shares are available for every one already borrowed. That is well above the 52-week low of 474%, and marks a dramatic reversal from late September when availability tightened toward the 900% range as shorts built positions. Cost to borrow is negligible at 0.43%, barely changed on the week despite a 13% rise in short shares outstanding. Short interest has climbed 13% over the past week to around 2.5 million shares, but from a very low base, and the borrow market's looseness suggests there is no squeeze pressure anywhere in the structure. Options traders are equally relaxed: the put/call ratio of 0.29 is fractionally below its 20-day average of 0.30, sitting near the 52-week low of 0.26, and barely a fifth of a standard deviation from its recent mean. Investors who might be expected to hedge a 32% monthly decline are not reaching for protection.

The fundamental picture has a peculiar character. Valuation multiples are extreme by any measure: the price-to-earnings ratio is below 2, price-to-book is 0.17, and EV/EBITDA is under 0.5, readings that place the stock in deep-discount territory on paper. The earnings momentum factor score of 6 out of 100 reflects sharply deteriorating EPS estimates over both 30 and 90 days. The dividend factor scores at the 98th percentile, consistent with the elevated forward yield that has accompanied the share price collapse, but a yield that high on a name experiencing this trajectory warrants care. The ORTEX combined score of 31.7 reflects the tension between cheap valuation and collapsing momentum.

The insider register carries the most telling near-term signal. Director Andrew Yan sold approximately 657,000 shares in late September at prices around $7.35 to $7.52, raising about $4.9 million in net proceeds over 90 days, and those transactions were not conducted under a 10b5-1 plan. Those sales occurred at prices well above where the stock now trades. The activist register adds one more layer: Aerovane Company Limited filed a Schedule 13D/A disclosing a 17.9% stake, making it a registered activist holder, though that filing dates to December 2025 and the stock has fallen sharply since. As always with 13D/G filings, stakes are as-last-disclosed around the 5% threshold, and positions can change without further disclosure.

Chinese fintech peers are also under pressure. LX fell 9.1% on the week and FINV dropped 5.5%, suggesting the sector as a whole is facing selling rather than idiosyncratic QFIN stress. The next earnings print is scheduled for November 17, and given that the last two quarterly reports produced one-day moves of around minus 15% and minus 20% respectively, the question heading into that date is whether the absence of put buying reflects genuine calm or simply a market that has stopped hedging a name it has already largely sold.